[Knocking-out extra domain A alternative splice fragment of fibronectin using a clustered regularly interspaced short...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Salivary adenoid cystic carcinoma (SACC) is an aggressive cancer.
• Fibronectin extra domain A (EDA) is implicated in cancer progression.
• The clustered regularly interspaced short palindromic repeats (CRISPR)/associated proteins (Cas) system offers precise gene editing capabilities.

Purpose of the Study:

• To investigate the role of fibronectin extra domain A (EDA) in SACC cell aggressiveness.
• To utilize the CRISPR/Cas9 system for targeted EDA knockout in SACC cells.

Main Methods:

• Designed a single guide RNA (sgRNA) to target EDA exon sequences.
• Transfected SACC-83 cells with sgRNA-containing PX-330 plasmid.
• Confirmed EDA knockout via PCR and DNA sequencing.
• Selected EDA-deficient SACC cell clones.
• Assessed cell proliferation and invasion using CCK-8 assays.

Main Results:

• Successful sgRNA integration and transfection.
• Achieved over 70% EDA knockout efficiency in SACC-83 cells.
• Selected three distinct EDA-absent SACC cell clones.
• Demonstrated significantly diminished migration and proliferation in EDA-deficient cells.
• Total fibronectin levels remained largely unchanged.

Conclusions:

• The CRISPR/Cas9 system provides efficient gene knockout for studying SACC.
• EDA knockout effectively inhibits SACC cell mobility and invasiveness.
• Targeting EDA presents a potential therapeutic strategy for SACC.